Drug Profile
Lenograstim biosimilar - Biosidus
Alternative Names: Lenobio; Lenograstim Biosidus; Leumostin™Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Biosidus S.A.
- Class Chemoprotectants; Granulocyte colony-stimulating factors
- Mechanism of Action Granulocyte colony-stimulating factor replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Neutropenia
Most Recent Events
- 10 Aug 2011 Launched for Neutropenia in Argentina (Parenteral)